The S&P 500's technology sector just ended its worst week since early September, after Chinese artificial-intelligence company DeepSeek seemed to startle investors' perception of winners and losers in ...
The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback